XASX
PKY
Market cap3mUSD
Aug 27, Last price
0.02AUD
Name
Opyl Ltd
Chart & Performance
P/E
—
P/S
13.60
EPS
—
Div Yield, %
—
Shrs. gr., 5y
58.73%
Rev. gr., 5y
-15.57%
Revenues
398k
-35.65%
Net income
-3m
L+81.31%
CFO
-2m
L+50.75%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in St Kilda, Australia, Opyl Limited, originally incorporated in 1994 as ShareRoot Limited before its rebranding in December 2019, specializes in developing digital innovations that significantly improve the healthcare journey for Australian patients. The company also offers valuable market intelligence gleaned from social media data and works to optimize clinical research procedures. Among its key offerings is Opin, an advanced platform for recruiting participants into clinical trials, which effectively connects patients with appropriate studies by utilizing social media, search engine optimization, and artificial intelligence. Additionally, Opyl provides comprehensive social media marketing agency services, including client and account management, specifically catering to the pharmaceutical, medical technology, and biotechnology industries.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||